Discover Great Companies Discover Great Clients

GSK

Popularity  12.7万   |   Followers  48   |   Likes  23   |   Feedback  52 Claim this company

We are a science-led global healthcare company

No.461 Shanghai Popularity Ranking No.24 Huangpu District No.2 Dong Wu Shi Yan No.2 Zhong Liu Yao Products No.4 Health Products No.4 Genetic Engineering No.5 Shen Jing Xi Tong Ji Bing Yao Products No.6 Kang Gan Ran Yao Products No.6 Rare Diseases No.8 Kang Zhong Liu Yao No.8 Sheng Wu Zhi Agents No.9 Health Products No.11 Vaccines Technology No.11 Ren Yong Yi Miao 副会长单位 理事单位
More

Company Overview

  • Nature: Foreign-funded enterprise Size: 10,000+ employees Founded: 28年
  • Industry: Pharmaceutical/Biotechnology 、 Finance/Investment/Securities
  • Full name: GlaxoSmithKline (China) Investment Co., Ltd.。

Development Stage

  • Ranking: Ranked #461 in Shanghai by popularity Ranked #2 in Shanghai Dong Wu Shi Yan Company by popularity Ranked #2 in Shanghai Zhong Liu Yao Products Company by popularity Ranked #4 in Shanghai Health Products Company by popularity Ranked #4 in Shanghai Genetic Engineering Company by popularity
  • Honors: 副会长单位 理事单位 According to algorithm
  • News: 2026-11-15:葛兰素史克:两款创新生物制剂纳入新版国家医保目录。
  • Salary: 63.4% of positions earn 10-20K, In 2026 vs last yeargrew by 9%.。Master's salary: ¥37.2K, Doctorate salary: ¥50.0K.
  • R&D: "Electronics/Electrical/Communication Technology" demand: 23.8%, "Medical & Health/Beauty & Healthcare": 22.2%, "Computer/Network/Technology": 4.7%。
  • Recruiting: In 2026 vs 2025decreased by 4%. Demand for highly educated talent: Master's: 29, Doctorate: 4.
  • Requirement: Education: 大专 leads with 48.8%. Experience: 1-3年 leads with 45.4%.
  • Region: Distributed across 36 regions, 上海: 14.1%, 北京: 10.5%, 郑州: 3.3%, 广州: 3.1%.

About the Company

[Summary] We are a science-led global healthcare company

Our mission and ambition
GlaxoSmithKline (GSK) is a global biopharmaceutical company with a mission to "unite science, technology, and talent to get ahead of disease together."

We are committed to positively impacting the health of 2.5 billion people over the next decade. Our new commitment to growth and transformative performance demonstrates our high aspirations for patients. At the same time, we are a company where outstanding talent can thrive and reach their full potential.

In China, we have always been dedicated to helping improve the health, lives, and future of the Chinese people.

Our presence in China
Business covers more than 250 cities and regions across China
5 regional centers: Beijing, Shanghai, Chengdu, Guangzhou, Hangzhou
1 national commercial operations center in Shanghai
1 research and development center in Shanghai
1 institute for infectious diseases and public health in Beijing

Our business in China
Vaccines: We are committed to increasing the accessibility of vaccines for Chinese patients and consumers. Our pediatric and adult vaccines can prevent a variety of diseases: shingles vaccine, cervical cancer vaccine, and hepatitis B vaccines available in both adult and pediatric formulations.
Prescription medicines: Our prescription medicine business has a rich portfolio of innovative and mature products. In China, we currently focus on the following therapeutic areas: respiratory, hepatitis, neurological diseases, HIV/AIDS, immune system diseases including systemic lupus erythematosus, and rare diseases including pulmonary arterial hypertension and eosinophilic granulomatosis with polyangiitis (EGPA).

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

GSK How Fast Is Hiring Growing? (205 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 338%
  • 2024: Down 71%
  • 2023: Up 15%
  • 2022: Down 57%
GSK Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
GSK Campus Recruitment & Advanced Degree Talent Demand
Master's 29 Doctorate 4
Note: How fast is hiring at GlaxoSmithKline (China) Investment Co., Ltd. growing? GSK2026: 491 openings (down 4%), 2025: 512 openings (up 338%), 2024: 117 openings (down 71%), 2023: 408 openings (up 15%), 2022: 354 openings (down 57%), 2021: 829 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

GSK Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 118%
  • 2024: Up 120%
  • 2023: Down 72%
  • 2022: Down 25%
GSK Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at GlaxoSmithKline (China) Investment Co., Ltd. growing? GSKMaster's recruitment over the years: 2025: 24 openings (up 118%), 2024: 11 openings (up 120%), 2023: 5 openings (down 72%), 2022: 18 openings (down 25%), 2021: 24 openings. GSK master talent ranking in Shanghai: #156, GSK master salary mostly around 20-50K.

GSK Doctoral Degree Job Demand Analysis

(More)
+700%
Growth Rate
2026 vs 2025
GSK Doctoral Hiring by Year: 2026 — 7 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
No.149
Doctoral Demand Ranking in Shanghai 򀀩
¥50K and above-50K and above
Doctoral Salary 򀀩
How fast is doctoral hiring at GlaxoSmithKline (China) Investment Co., Ltd. growing? GSKDoctorate recruitment over the years: 2026: 8 openings (up 171%), 2025: 1 openings (up 118%). GSK doctorate talent ranking in Shanghai: #149, GSK doctorate salary mostly around 50K and above-50K and above.

GSK R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at GlaxoSmithKline (China) Investment Co., Ltd.? Based on an analysis of GSK's job postings over the past year, "Electronics/Electrical/Communication Technology" demand: 23.8%, "Medical & Health/Beauty & Healthcare": 22.2%, "Computer/Network/Technology": 4.7%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 0.6%, "Surveying and Mapping Technology": 0.3%. For reference only.

GSK — What Are the Salaries Like? (661 records)

Manage
GSK Salary Overview
salary range: 8K - 50K, 63.4% of roles pay ¥10-20K
Note: salary statistics are based on 661 salary records from the past year and depend on the job sample. For reference only.
How is the salary at GlaxoSmithKline (China) Investment Co., Ltd.?GSK63.4% of positions earn 10-20K, Undergraduate salary: ¥。Shanghai salary ranking top 50,销售类 average salary ¥16.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of GSK

(More)
Are salaries high at GlaxoSmithKline (China) Investment Co., Ltd.? We provide: Pharmaceutical Sales Representative, PR, MA, Executive Assistant, Process Engineer, RA, Medical Science Liaison, Test Engineer, Regional Manager, Organization Culture Specialist, pi, Industrial Engineer, Investor Relations, CTO, Account, Key Account, Account Manager, Sales, Marketing, Medical Science Liaison. Click to view detailed salary analysis by job.

GSK honors, qualifications & industry associations

Job Category

  • 销售类
    75.9% of total 75.9%
  • 电子/电器/通信技术类
    23.7% of total 23.7%
  • 工厂生产类
    22.3% of total 22.3%
  • 医疗卫生/美容保健类
    22.2% of total 22.2%

Education

  • 大专
    48.8% of total 48.8%
  • 本科
    28.7% of total 28.7%
  • 不限
    11.1% of total 11.1%
  • 硕士
    10.1% of total 10.1%

Experience

  • 1-3年
    45.4% of total 45.4%
  • 3-5年
    23.8% of total 23.8%
  • 5-10年
    16.7% of total 16.7%
  • 不限
    14.1% of total 14.1%
View Detailed Analysis

What does GlaxoSmithKline (China) Investment Co., Ltd. require? Who is GSK hiring? GSK recruitment: 销售类占比最多占75.9%,其次是电子/电器/通信技术类占23.7%. What education can get in at GSK? 大专占比最多占48.8%,其次是本科占28.7%. High education required at GSK? 硕士占10.1%,博士占1.3%. Work experience required at GSK? 1-3年占比最多占45.4%,其次是3-5年占23.8%. Where are the job locations at GSK? 上海占比最多占14.1%,其次是北京占10.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 150,976.8846万(元)
Legal Representative: 余慧明
Date Established:
Credit Code: 91110000710920274M
Registered Address: 北京市朝阳区东四环中路56号楼9层901单元901、902、903、905、908、909、910房间

Partners & Suppliers

授权GSK在东南亚等地区开发、生产和销售万泰的HPV疫苗 Source
供应商 技术授权合作
为GSK提供临床研究服务 Source
供应商 大型跨国制药企业
向上海医药供应呼吸、HIV等处方药及疫苗 Source
合作客户 医药分销(供应商-跨国制药企业)
供应呼吸系统、疫苗等药品 Source
合作客户 品牌药企(化药)
合恩医药为葛兰素史克在福建省的配送商,采购其疫苗、呼吸等产品。 Source
合作客户 化学药

People who follow GSK also follow

GSK Competitors (Similar Companies)

“To develop high-quality biologics that are accessible and affordable f”
“We focus on scientific innovation, exploring, developing, and providin”
“Continuously innovating to bring patients medicines that significantly”
“Research, development, and production of anti-tumor and surgical medic”
“Improving people's quality of life”
“慢病管理的有力践行者”
“Dedicated to the research and development of molecularly targeted drug”
“Customer-oriented, performance excellence, strict integrity, and winni”
“A leading open-access capability and technology platform company for p”
“Professional integrated drug discovery and development services from t”
“Rapid test product R&D and manufacturer”
“A pharmaceutical enterprise with over 70 years of glorious history”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Providing solutions for personalized treatment and health management”
医疗器械 神经系统疾病药物 研发 核酸

Discover Great Companies, Discover Great Clients

上海公司名录 上海“Huangpu District”公司名录 上海“生物制品”公司名录 上海“疫苗”公司名录 上海“人用疫苗”公司名录 上海“基因工程”公司名录 上海“制药/药业”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates